Scarica l'app Stockscreener
0.80
0.80%
-0.01
Dopo l'orario di chiusura:
.81
0.01
+1.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SCYX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.81
Aprire:
$0.83
Volume 24 ore:
552.36K
Relative Volume:
1.59
Capitalizzazione di mercato:
$33.54M
Reddito:
$3.26M
Utile/perdita netta:
$-19.52M
Rapporto P/E:
-2.00
EPS:
-0.4
Flusso di cassa netto:
$-24.10M
1 W Prestazione:
+1.50%
1M Prestazione:
-24.20%
6M Prestazione:
-11.95%
1 anno Prestazione:
-47.82%
Intervallo 1D:
$0.80
$0.8499
Intervallo di 1 settimana:
$0.76
$0.905
Portata 52W:
$0.66
$1.62
Scynexis Inc Stock (SCYX) Company Profile
Nome
Scynexis Inc
Settore
Telefono
201-884-5485
Indirizzo
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Confronta SCYX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
0.80 | 34.06M | 3.26M | -19.52M | -24.10M | -0.40 |
|
ZTS
Zoetis Inc
|
143.24 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.89 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.185 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.62 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-01-22 | Iniziato | Guggenheim | Buy |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-07-11 | Aggiornamento | Needham | Hold → Buy |
| 2018-06-27 | Iniziato | Maxim Group | Buy |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2017-07-10 | Iniziato | ROTH Capital | Buy |
| 2017-05-09 | Downgrade | Needham | Buy → Hold |
| 2017-03-03 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-10-20 | Iniziato | H.C. Wainwright | Buy |
| 2016-10-07 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | Ripresa | Brean Capital | Buy |
| 2016-08-17 | Iniziato | Guggenheim | Buy |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-08-09 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | Iniziato | Brean Capital | Buy |
| 2015-12-29 | Iniziato | WBB Securities | Speculative Buy |
| 2015-11-16 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-06-10 | Iniziato | Needham | Buy |
| 2014-05-29 | Iniziato | Canaccord Genuity | Buy |
| 2014-05-29 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Scynexis Inc Borsa (SCYX) Ultime notizie
What MACD signals say about SCYNEXIS Inc.Weekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Building trade automation scripts for SCYNEXIS Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Using R and stats models for SCYNEXIS Inc. forecasting2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
SCYNEXIS, Inc. and GlaxoSmithKline Intellectual Property (No. 3) Limited Enter into Binding Memorandum of Understanding for Amendment to Exclusive License Agreement - MarketScreener
SCYNEXIS receives $22 million from GSK as MARIO study ends - Investing.com
SCYNEXIS (SCYX) Secures $22 Million from GlaxoSmithKline Settlem - GuruFocus
SCYNEXIS and GSK Amend License Agreement - TipRanks
Scynexis to receive $24.3 million from GSK as MARIO study ends per new agreement - Investing.com
SCYNEXIS to Receive $22 Million Payment from GSK Following MARIO Study Termination - Quiver Quantitative
Scynexis and GSK resolve their disagreement related to the restart of the phase 3 MARIO Study - MarketScreener
SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study - The Manila Times
Published on: 2025-10-15 06:26:13 - newser.com
Why SCYNEXIS Inc. stock remains resilientTrade Risk Assessment & Consistent Growth Equity Picks - newser.com
Statistical indicators supporting SCYNEXIS Inc.’s strength2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
How interest rate cuts could boost SCYNEXIS Inc. stockWeekly Market Summary & Stock Market Timing Techniques - newser.com
How strong is SCYNEXIS Inc. (135A) stock earnings growthWeekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
SCYNEXIS Inc. stock daily chart insightsPortfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Does SCYNEXIS Inc. fit your quant trading modelMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
Why SCYNEXIS Inc. (135A) stock could rally stronglyJuly 2025 Highlights & Free Verified High Yield Trade Plans - newser.com
Regression analysis insights on SCYNEXIS Inc. performanceMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Is SCYNEXIS Inc. stock ready for a breakoutWeekly Gains Report & Real-Time Market Sentiment Alerts - newser.com
Trend analysis for SCYNEXIS Inc. this weekJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Has SCYNEXIS Inc. found a price floorJuly 2025 Update & High Accuracy Trade Alerts - newser.com
Technical signs of recovery in SCYNEXIS Inc.Stop Loss & Safe Entry Momentum Tips - newser.com
What momentum shifts mean for SCYNEXIS Inc.Bear Alert & Daily Entry Point Trade Alerts - newser.com
How SCYNEXIS Inc. stock reacts to Fed rate cuts2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Can SCYNEXIS Inc. (135A) stock attract analyst upgradesJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
SCYNEXIS Inc. recovery potential after sell offJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
What data driven models say about SCYNEXIS Inc.’s futureJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Multi asset correlation models including SCYNEXIS Inc.July 2025 Recap & Expert Curated Trade Ideas - newser.com
What institutional flow reveals about SCYNEXIS Inc.Long Setup & Reliable Intraday Trade Alerts - newser.com
Scynexis Inc Azioni (SCYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.02%
5.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):